An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Clinical trial NCT03735628 · COMPLETED

Trial details

NCT number: NCT03735628
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Hepatocellular Carcinoma (HCC)

Start date: 2018-10-17
Primary completion: 2022-10-13
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.